Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

Published:2004-01 Issue:1 Volume:58 Page:161-166
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Calais Gilles,Bardet Etienne,Sire Christian,Alfonsi Marc,Bourhis Jean,Rhein Béatrix,Tortochaux Jacques,Man Yooye Tao Kong,Auvray Hugues,Garaud Pascal

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma;Calais;J Natl Cancer Inst,1999

2. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer;Brizel;N Engl J Med,1998

3. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy;Merlano;N Engl J Med,1992

4. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer;Adelstein;Head Neck,1997

5. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer;Wendt;J Clin Oncol,1998

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Addition of Docetaxel to Platinum Based Concurrent Chemoradiation Improves the Response and Survival in Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck; Phase II Study;Eurasian Journal of Medicine and Oncology;2024

2. Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation;Journal of Clinical Oncology;2023-05-01

3. Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy;Chemotherapy;2022-07-26

4. Treatment for Locoregionally Recurrent Head and Neck Cancers;Korean Journal of Otorhinolaryngology-Head and Neck Surgery;2022-03-21

5. Applying nomograms based on the surveillance, epidemiology and end results database to predict long-term overall survival and cancer-specific survival in patients with oropharyngeal squamous cell carcinomas;Medicine;2020-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3